Introduction {#s1}
============

Mitochondrial density and capacity for oxidative ATP synthesis in skeletal muscle are tightly linked to cellular energetic demands (Spina et al., [@B53]; Egan and Zierath, [@B12]). Protein deacetylases such as sirtuins (SIRTs) are important modulators of gene expression and protein activity and are involved in mitochondrial biogenesis. SIRT1 is mainly located in the nucleus and deacetylates the transcriptional coactivator, peroxisome proliferator-activated receptor γ-coactivator 1α (PGC-1α) (Nemoto et al., [@B38]), thereby increasing mitochondrial biogenesis (Puigserver et al., [@B42]) and improving mitochondrial function (Gerhart-Hines et al., [@B15]). PGC-1α also induces gene expression of the mitochondrial sirtuin SIRT3 (Schwer et al., [@B50]) in muscle cells and hepatocytes (Kong et al., [@B27]).

SIRT3 modulates mitochondrial gene expression and function. SIRT3-driven processes occur via a general deacetylation of mitochondrial proteins (Lombard et al., [@B34]), including key elements of the citric acid cycle and proteins involved in oxidative phosphorylation (Hallows et al., [@B18]; Schwer et al., [@B49]; Wu et al., [@B62]; Vassilopoulos et al., [@B60]), or reactive oxygen species (ROS) handling (Someya et al., [@B52]; Tseng et al., [@B59]). Thus, SIRT1 may increase SIRT3 expression via PGC-1α deacetylation to facilitate an increase in mitochondrial function and/or density.

Exercise training and caloric restriction (CR) induce mitochondrial biogenesis, but SIRT1-mediated adaptations to exercise and CR are blunted in AMP-activated protein kinase (AMPK)-deficient skeletal muscle (Cantó et al., [@B9]). AMPK is a heterotrimeric protein consisting of multiple catalytic (α1, α2) and regulatory (β1, β2, γ1, γ2, γ3) subunits. AMPK functions as a major sensor of cellular energy status and can be activated pharmacologically and in response to muscle contraction and CR (Koh et al., [@B26]). Importantly, AMPK directly phosphorylates PGC-1α (Jäger et al., [@B21]) which may result in SIRT1-mediated deacetylation and activation of PGC-1α (Cantó et al., [@B8]) and thus link cellular energy status, mitochondrial biogenesis, and ROS handling.

AMPK activation via 5-amino-1-β-D-ribofuranosyl-imidazole-4-carboxamide (AICAR) increases SIRT3 mRNA level in hepatocytes (Buler et al., [@B7]). While SIRT3 reduces oxidative stress induced by CR (Someya et al., [@B52]), AMPK partly coordinates the cellular response to CR (Shinmura et al., [@B51]), supporting the hypothesis that AMPK may regulate SIRT3.

Exercise training increases ROS processing in skeletal muscle (Parise et al., [@B41]) via a mechanism that is incompletely understood. A potential mitochondrial signaling cascade response involving SIRT3 and FOXO3A-dependent transcription of catalase and MnSOD has been proposed (Jacobs et al., [@B20]), but the role of this cascade in exercise-training induced adaptations is unknown. MnSOD and catalase govern the conversion of superoxide to water and oxygen in sequential steps (Reid, [@B46]). Activation of MnSOD is enhanced by SIRT3-dependent deacetylation at K122, enabling the cell to scavenge ROS (Tao et al., [@B55]). Other regulatory acetylation sites have also been reported (Qiu et al., [@B44]; Chen et al., [@B11]), but the importance for each of these sites in relation to different stimuli remains elusive.

In summary, activation of AMPK via exercise or pharmacological treatment may phosphorylate PGC-1α, increase SIRT3 protein expression, and enhance the ability of skeletal muscle to better handle ROS via deacetylation and activation of MnSOD. Whether this pathway is redundant or exclusively dependent on AMPK is unknown. Given the functional connection between AMPK activators and PGC-1α-dependent increases of SIRT3 abundance and its downstream targets, we determined the effects of exercise training and pharmacological AMPK activation via AICAR in mouse models overexpressing a kinase dead version of the catalytic α2 AMPK subunit dominant in skeletal muscle as well as in skeletal muscle of PGC-1α deficient mice.

Materials and methods {#s2}
=====================

Exercise training---humans
--------------------------

Skeletal muscle samples were obtained from young male subjects previously described in an earlier study (Frøsig et al., [@B13]). The exercise training study was performed in compliance with the Helsinki II Declaration, with approval from the local ethics committee (\#KF 01-070/96). Exercise training consisted of 15 sessions of one-legged knee extensor endurance training over the course of 3 weeks. The duration of the exercise sessions started at 1 h per session and was gradually increased to 2 h per session for the final 5 sessions. Needle biopsies were obtained under local anesthesia (2% lidocaine) from the right and left *vastus lateralis* muscles before training and 15 h (*n* = 8) after the final exercise bout.

Acute exercise---humans
-----------------------

*Vastus lateralis* muscle samples were obtained from healthy young men before and after an acute bout of one-legged knee-extensor exercise. Selected data from this experiment have been published previously (Treebak et al., [@B58]). This study was approved by the local ethics committee (\#KF 1277313) and complied with the Helsinki II Declaration. Seven subjects volunteered to perform an acute bout of one-legged knee-extensor exercise at 80% of peak work load for 1 h during the morning after an overnight fast. In the 1-h exercise bout, peak work load was increased to 100% for 5 min intervals after 15 min and again after 35 min. Needle biopsies from the right and left *vastus lateralis* muscle were obtained before (Pre) and immediately after (Post) exercise cessation as described (Treebak et al., [@B58]).

Animal experiments
------------------

All animal experiments complied with the European Convention for the protection of Vertebrate Animals used for Experiments and Other Scientific Purposes (Council of Europe 123, Strasbourg, France, 1985) and were approved by the Danish Animal Experimental Inspectorate (\#2012-15-2934-26 and \#2012-15-2934-307).

Exercise training---mice
------------------------

Female mice (9--15 weeks of age) overexpressing a kinase dead (KD) α2 AMPK subunit in skeletal muscle (Mu et al., [@B36]) or WT littermates underwent 6.5 weeks of endurance exercise training (*n* = 12--15/group). Selected data from these experiments have been published previously (Brandauer et al., [@B6]). Mice had free access to running wheels for voluntary running 7 days/week. Running distance was recorded using a cycle odometer (\#BC1009, Sigma Sport®, Germany). WT and AMPK α2 KD mice performed similar amounts of voluntary running (Brandauer et al., [@B6]). In addition, mice were exercised 1 h/day at 16 m/min on a motorized treadmill (Exer-3/6, Columbus Instruments) on weekdays as described (Brandauer et al., [@B6]). The treadmill was horizontal the first week, and the incline was increased by 2.5° per week up to 10° where it remained for the duration of the study. The morning following the final exercise bout, mice were anesthetized by an intraperitoneal (i.p.) injection using Avertin (250 mg tribromoethanol/kg body weight). Quadriceps muscles were removed, snap-frozen in liquid nitrogen, and stored at −80°C until further analyses.

AICAR treatment studies
-----------------------

To determine whether AICAR-induced increases in SIRT3 and other mitochondrial proteins depend on AMPK, male AMPK α2 KD and WT mice (11--12 weeks of age) received a daily subcutaneous injection of 500 mg/kg body weight AICAR or 0.9% NaCl solution for 4 weeks (*n* = 7--8) as described (Brandauer et al., [@B6]). Mice were anesthetized via i.p. injection of Avertin (250 mg/kg body weight) 24 h following the last AICAR/vehicle treatment to avoid any confounding effects of the last AICAR/saline injection. Quadriceps muscle was obtained, snap-frozen in liquid N~2~, and stored at −80°C. Samples from a previously published study of male and female whole-body PGC-1α KO and WT mice were also analyzed. The mice in this study were treated with AICAR under the same conditions as described above (Leick et al., [@B31], [@B30]). In order to determine the acute effect of a single injection of AICAR, we analyzed samples originating from a previous study (Leick et al., [@B30]). Male and female PGC-1α KO mice and WT littermates (*n* = 6--8) were injected subcutaneously with a single dose of AICAR (500 mg/kg body weight) or saline. Quadriceps muscles were taken 4 h after the injection, snap-frozen in liquid N~2~ and stored at −80°C.

Acute exercise in previously trained or untrained mice
------------------------------------------------------

To assess the effects of acute exercise in trained and untrained mouse skeletal muscle, female C57BL/6JBom (Taconic, Denmark) mice (9--10 weeks of age) underwent 5.5 weeks of endurance exercise training (*n* = 26) or served as sedentary controls (*n* = 24). The training consisted of voluntary running with free access to wheel cages 7 days/week with running distance being recorded by a cycle odometer (\#BC1009, Sigma Sport®, Germany). In addition, mice were exercised 1 h/day on weekdays with accelerating speeds from 8 to 18 m/min on a motorized treadmill (Exer-3/6, Columbus Instruments) or placed on a "mock" treadmill for the sedentary control group. The treadmill was horizontal the first week, and the incline was increased by 2.5° per week up to 10° at the final week to account for increased performance and to ensure a continuous training stimulus. Untrained control animals were acclimatized to treadmill running for 15--20 min with accelerating speeds from 8 to 18 m/min at a 5° incline for three consecutive days, with 1 day of rest prior to the acute exercise experiment. On the experimental day, both trained and sedentary control mice were divided into three groups: non-exercised controls (*n* = 8 sedentary, 9 trained), and mice performing either moderate-intensity (*n* = 8 sedentary, 8 trained) or high-intensity acute exercise (*n* = 7 sedentary, 8 trained), resulting in six experimental groups. Based on the recorded running distances of each mouse, mice were assigned to one of the three groups so that the average amount of training performed in the training period was similar between the three groups (i.e., 5.1 ± 0.6 km/day; mean ± SEM). Mice then performed an acute treadmill exercise bout for 1 h or served as sedentary controls. "Moderate intensity" was defined as 12 m/min at 0° incline, while "high intensity" was defined as 18 m/min with a 10° incline. Mice were euthanized by cervical dislocation immediately after the acute exercise bout. Quadriceps muscles were quickly removed, snap frozen in liquid nitrogen, and stored at --80° until further analysis.

Tissue processing and western blot analyses
-------------------------------------------

All muscle samples were processed using steel bead homogenization (Tissue Lyser II, Qiagen) in ice-cold lysis buffer (pH 7.4; 10% glycerol; 1% IGEPAL; Hepes, 50 mM; NaCl, 150 mM; NaF, 10 mM; EDTA, 1 mM; EGTA, 1 mM; sodium pyrophosphate, 20 mM; sodium orthovanadate, 2 mM; sodium-pyrophosphate 1 mM; nicotinamide 5 mM; Thiamet G 4μM and protease inhibitors (SigmaFast, Sigma Aldrich) according to manufacturer\'s instructions). Protein concentrations were determined using BCA assays (Thermo Scientific, \#23223 and \#23224). Equal amounts of protein were resolved by SDS-PAGE and transferred to polyvinylidene difluoride (PVDF) membranes (Millipore, Denmark) as described (Brandauer et al., [@B6]). Western blots were executed in a balanced design, with samples from all experimental conditions present on all gels, and identical internal control samples included on each blot. The internal control sample was prepared as a pool of all samples from a given experiment. All samples on individual gels were normalized to the internal control sample in order to permit comparison of samples resolved on separate gels. Following transfer, samples were subjected to immunoblot analysis to detect protein abundance using following antibodies against SIRT3 (Cell Signaling, \#5490S), SIRT1 (Millipore, \#07-131), MnSOD, (Millipore, \#06-948), MnSOD K122 acetylation (kindly provided by Prof. David Gius, Northwestern University Feinberg School of Medicine, Chicago, Illinois; see Tao et al., [@B55]) and Catalase (R&D Systems, \#AF3398). Protein abundance of the oxidative phosphorylation complexes was determined using antibodies against Complex I (NDUFB8, Invitrogen, \#459210), Complex II (Fp subunit, Invitrogen, \#459200), Complex III (Core subunit I, Invitrogen, \#459140), Complex IV (Subunit I, Invitrogen, \#459600), Complex V (i.e., F1F0 ATP synthase; oligomycin-sensitivity conferring protein \[OSCP\] subunit (Santa Cruz, \#sc-74786), cytochrome C (BD Biosciences \#556433) and OSCP K139 acetylation (kindly provided by Prof. David Gius). The specificity of the MnSOD K122 and OSCP K139 antibody used in this study has been verified (Tao et al., [@B55]; Vassilopoulos et al., [@B60]) and was confirmed by "split-blot" analyses, where samples prepared from the same mouse quadriceps muscle or human *vastus lateralis* muscle was resolved in three adjacent wells. After transfer to PVDF, the membrane was cut through the center well and the membrane halves were probed with the total MnSOD/OSCP or MnSOD K122/OSCP K139 antibodies, respectively. Complete alignment of the bands was confirmed (**Figure 7**).

Quantitative polymerase chain reaction (qPCR)
---------------------------------------------

qPCR was performed as described (Brandauer et al., [@B6]). RNA from quadriceps muscles was extracted using Trizol (Invitrogen, \#15596-018) and reverse transcription was performed using iScript cDNA synthesis kit (BioRad, \#170-8891). Real-time qPCR was performed using 2μl of template cDNA, 300 nM of sense and antisense oligonucleotides and SYBR Green PCR Master Mix (AH Diagnostic, \#600882) in a final volume of 10 μl. Fluorescence measurements and data analysis were performed on the CFX96 real time system (BioRad). Gene expression was determined using primer sequences: SIRT3 forward primer: 5′-TACAGAAATCAGTGCCCCGA-3′ and reverse primer: 5′-GGTGGACACAAGAACTGCTG-3′; MnSOD forward primer: 5′-ACTGAAGTTCAATGGTGGGG- 3′ and reverse primer: 5′-GCTTGATAGCCTCCAGCAAC- 3′ and normalized by input cDNA (Qubit ssDNA assay kit, Invitrogen, \#Q10212).

Statistics
----------

Statistical analyses were performed by either 2 × 2 analysis of variance (ANOVA), by 2 × 3 ANOVA, or by 2 × 2 repeated-measures ANOVA as appropriate. The Tukey test was used *post-hoc*. If statistical interactions were borderline significant (0.05 \< *p* \< 0.1) and the observed power was low (\<0.5), individual *t*-tests were performed as noted in the description of the results. As incomplete sample sets are excluded from statistical analyses in repeated-measures ANOVA, statistical analyses performed on data from the human training study were only performed on 6 sets of samples. Statistical significance was set at *p* \< 0.05. All data are reported as mean ± SEM.

Results {#s3}
=======

Exercise training in mice increases SIRT3 and MnSOD in an AMPK-dependent manner
-------------------------------------------------------------------------------

To verify the potency of the exercise training program and to assess the importance of AMPK on exercise-induced mitochondrial adaptations in skeletal muscle, we performed Western blot analyses on mitochondrial Complex I through V (OSCP) and cytochrome C on samples from WT and AMPK α2 KD mice that had completed 6.5 weeks of endurance exercise training. WT and AMPK α2 KD mice performed similarly in average distance run (Brandauer et al., [@B6]), average duration of exercise/day (WT, 140 ± 16 min/day; KD, 168 ± 29 min/day; *p* = 0.38) and average running speed (WT, 1.39 ± 0.04 km/h; KD, 1.27 ± 0.07 km/h, *p* = 0.15).

We found no interaction effects in any of the data sets presented in Figures [1A--F](#F1){ref-type="fig"}, likely due to low statistical power. However, if individual *t*-tests were performed between control and trained mice, we found significant (*p* \< 0.05) increases in Complexes I, II, and IV protein abundance in the WT mice only. Collectively, these data suggest a regulatory role for AMPK in mediating the effects of endurance exercise training on mitochondrial protein expression.

![**Exercise training increase mitochondrial oxidative phosphorylation complexes in an AMPK α2-dependent manner**. Protein levels of oxidative phosphorylation complexes, **(A)** Complex I, **(B)** Complex II, **(C)** Complex III, **(D)** Complex IV, **(E)** Complex V (oligomycin-sensitivity conferring protein subunit, OSCP), and **(F)** Cytochrome C were evaluated in quadriceps muscle of sedentary (control) or exercise trained female WT and AMPK α2 KD mice (*n* = 13--15). Values are mean ± SEM. ^\*^indicates vs. WT control (*p* \< 0.05) analyzed by unpaired *t*-tests.](fphys-06-00085-g0001){#F1}

Endurance exercise training increased SIRT3 protein abundance in skeletal muscle from WT, but not AMPK α2 KD mice (*p* \< 0.01; *n* = 12--15) (Figure [2A](#F2){ref-type="fig"}). On the other hand, no statistical differences in SIRT3 mRNA levels were observed between genotypes or in response to exercise training (Figure [2B](#F2){ref-type="fig"}). Exercise training tended to increase skeletal muscle MnSOD protein levels in WT relative to KD mice (WT, 49%; AMPK α2 KD, 11%; genotype × treatment interaction effect, *p* = 0.079; observed power 0.294; Figure [2C](#F2){ref-type="fig"}). A *t*-test showed an exercise-induced increase in skeletal muscle MnSOD protein level in WT (*p* \< 0.05), but not AMPK α2 KD mice. MnSOD mRNA levels were unchanged in response to exercise training in both genotypes (Figure [2D](#F2){ref-type="fig"}). Endurance exercise did not alter SIRT1 (Figure [2E](#F2){ref-type="fig"}) or catalase protein levels (Figure [2F](#F2){ref-type="fig"}). Thus, AMPK is required for upregulation of SIRT3 and MnSOD protein levels in response to exercise training.

![**Exercise training increases SIRT3 and MnSOD protein in mouse skeletal muscle in an AMPK α2-dependent manner. (A)** SIRT3 protein, **(B)** SIRT3 mRNA (*n* = 11--14), **(C)** MnSOD protein, **(D)** MnSOD mRNA (*n* = 11--14), **(E)** SIRT1 protein, and **(F)** Catalase protein levels were measured in quadriceps muscle of control or exercised trained female WT and AMPK α2 KD mice (*n* = 13--15 for protein measurements). Quadriceps muscles were obtained the day after the final bout of exercise. Values are mean ± SEM. An interaction effect (*p* \< 0.05; treatment × genotype) was present in **(A)**. ^\*^ indicates vs. WT control (*p* \< 0.05; analyzed by independent *t*-test), ^\*\*^ indicates vs. WT control (*p* \< 0.01), and † indicates genotype effect within trained groups (*p* \< 0.05).](fphys-06-00085-g0002){#F2}

Skeletal muscle MnSOD protein abundance is increased following endurance exercise training in human skeletal muscle
-------------------------------------------------------------------------------------------------------------------

We employed a model of one-legged endurance exercise training to study SIRT3 and MnSOD protein abundance in trained and untrained human skeletal muscle. A repeated-measures ANOVA revealed no significant changes in SIRT3 protein content following exercise training in humans (*n* = 6; Figure [3A](#F3){ref-type="fig"}). When samples were analyzed to determine MnSOD content, a borderline significant interaction effect (leg × intervention; *p* = 0.051, *n* = 6; observed power; 0.471; Figure [3B](#F3){ref-type="fig"}) was observed. A *t*-test comparing the control leg to the trained leg after the exercise intervention revealed MnSOD protein was increased in trained skeletal muscle (*p* \< 0.05). Collectively, our data indicate that protein content of MnSOD is upregulated in response to exercise training in human skeletal muscle.

![**One-legged knee-extensor endurance exercise training increases MnSOD protein levels in human *vastus lateralis* muscle**. Male individuals performed 15 sessions of 1--2 h of one-legged knee extensor endurance exercise training over a period of 3 weeks. SIRT3 and MnSOD protein levels were measured from biopsies obtained before training and 15 h after the last bout of exercise (*n* = 8). **(A)** SIRT3 and **(B)** MnSOD protein levels. A borderline interaction effect of leg × intervention (*p* = 0.051) was found for MnSOD protein levels (observed power 0.471). ^\*^ indicates vs. control leg after training (*p* \< 0.05; paired *t*-test). Values are mean ± SEM. Statistical analyses were performed for *n* = 6 due to incomplete sample sets.](fphys-06-00085-g0003){#F3}

Repeated AMPK activation by AICAR increases SIRT3 and MnSOD protein in an AMPK- and PGC-1α-dependent manner
-----------------------------------------------------------------------------------------------------------

To more directly confirm a role for AMPK in the regulation of skeletal muscle SIRT3 and MnSOD protein abundance, we treated WT and AMPK α2 KD mice with AICAR, a pharmacological AMPK activator. We performed Western blot analyses for proteins involved in oxidative phosphorylation to determine the efficacy of the AICAR treatment. Similarly to the results observed in the exercise training studies, any AICAR-induced increase in skeletal muscle abundance of oxidative phosphorylation complex proteins was blunted in AMPK α2 KD mice (Figures [4A--F](#F4){ref-type="fig"}). However, no significant interaction effects were found for Complex I-V, most likely due to low statistical power. When individual *t*-tests were performed, significant increases in protein content were found in the WT group for Complexes I, IV, and V. Treatment with AICAR increased abundance of cytochrome C in the WT mice (*p* \< 0.01) in an AMPK-dependent manner (treatment × genotype interaction effect *p* \< 0.05), and protein levels were lower in AMPK α2 KD mice (*p* \< 0.01; Figure [4F](#F4){ref-type="fig"}).

![**Repeated treatment with AICAR increases abundance of mitochondrial electron transport chain proteins in an AMPK α2-dependent manner**. WT and AMPK α2 KD male mice were given daily subcutaneous injections with AICAR (500 mg/kg body weight) or saline for 4 weeks. **(A--E)** Protein abundance of oxidative phosphorylation Complexes I--V and **(F)** Cytochrome C was measured in quadriceps muscle (*n* = 7--8). A significant interaction effect (treatment × genotype; *p* \< 0.05) was observed for Cytochrome C. Values are mean ± SEM. ^\*^ indicates vs. WT saline (*p* \< 0.05) analyzed by *t*-tests, ^\*\*^ indicates vs. WT saline (*p* \< 0.01), and †† indicates genotype effect within AICAR treated animals (*p* \< 0.01).](fphys-06-00085-g0004){#F4}

AICAR treatment resulted in AMPK α2-dependent increases in SIRT3 protein levels (treatment × genotype interaction effect *p* \< 0.05; *n* = 7--8; Figure [5A](#F5){ref-type="fig"}) whereas mRNA expression increased independent of genotype (*p* \< 0.01; Figure [5B](#F5){ref-type="fig"}). Likewise, MnSOD protein levels increased in an AMPK α2-dependent manner (treatment × genotype interaction effect *p* \< 0.05; *n* = 7--8; Figure [5C](#F5){ref-type="fig"}) while MnSOD mRNA expression increased in response to AICAR independent of AMPK α2 (*p* \< 0.01, *n* = 6--8; Figure [5D](#F5){ref-type="fig"}). Together, these data support the hypothesis that AMPK activation governs post-transcriptional regulation of SIRT3 and MnSOD protein levels. Repeated treatment with AICAR did not increase SIRT1 or catalase protein levels (Figures [5E,F](#F5){ref-type="fig"}).

![**Increases in quadriceps SIRT3 protein levels after repeated AICAR treatment are abolished in AMPK α2 KD mouse skeletal muscle**. Levels of **(A)** SIRT3 protein, **(B)** SIRT3 mRNA, **(C)** MnSOD protein, **(D)** MnSOD mRNA, **(E)** SIRT1 protein, and **(F)** Catalase protein were determined in quadriceps muscle from WT and AMPK α2 KD male mice (*n* = 7--8) treated with daily subcutaneous injections of AICAR (500 mg/kg body weight) or saline for 4 weeks. Values are mean ± SEM. Interaction effects (treatment × genotype) were present in **(A)** (*p* \< 0.05) and **(C)** (*p* \< 0.01). ^\*^ indicates vs. saline within genotype (*p* \< 0.05), ^\*\*^ indicates vs. saline within genotype (*p* \< 0.01), and †† indicates genotype effect within AICAR treated samples (*p* \< 0.01).](fphys-06-00085-g0005){#F5}

We next assessed whether increases in SIRT3 and MnSOD following AICAR treatment depend on functional PGC-1α signaling. AICAR treatment increased skeletal muscle protein level of SIRT3 and MnSOD in WT, but not in PGC-1α KO mice (treatment × genotype interaction effect *p* \< 0.05; *n* = 9--10; Figures [6A,B](#F6){ref-type="fig"}), and total protein of SIRT3 and MnSOD was generally reduced in control PGC-1α KO mice (*p* \< 0.01; *n* = 9--10; Figures [6A,B](#F6){ref-type="fig"}). SIRT1 and catalase protein levels were similar in the WT and PGC-1α mice and remained unaltered in response to repeated AICAR treatment (Figures [6C,D](#F6){ref-type="fig"}). These data suggest that SIRT3 and MnSOD protein abundance is regulated in a signaling axis involving both AMPK and PGC-1α. In an attempt to establish indirect evidence that upregulation of SIRT3 and MnSOD protein with AICAR is mediated through transcriptional regulation of the SIRT3 and MnSOD genes by a PGC-1α-dependent mechanism, we measured mRNA levels of SIRT3 and MnSOD in PGC-1α KO animals treated repeatedly with AICAR over 4 weeks. Although mRNA levels of both SIRT3 and MnSOD were reduced in the PGC-1α KO animals, no increase with AICAR was detected in either genotype (Figures [6E,F](#F6){ref-type="fig"}). To determine whether an acute AICAR injection would increase mRNA levels of SIRT3 and MnSOD, we analyzed samples from PGC-1α KO and WT mice taken 4 h after a single injection of AICAR/saline (Leick et al., [@B30]). As in the repeated-AICAR experiment, PGC-1α KO mice had lower mRNA levels of SIRT3 and MnSOD, but AICAR did not increase SIRT3 or MnSOD mRNA (Figures [6G,H](#F6){ref-type="fig"}).

![**AICAR-induced upregulation of SIRT3 and MnSOD protein in mouse skeletal muscle is dependent on PGC-1α**. WT and PGC-1α KO mice received daily subcutaneous injection of AICAR (500 mg/kg body weight) or saline for 4 weeks. Quadriceps muscles were obtained the day after the last injection. **(A)** SIRT3 protein, **(B)** MnSOD protein, **(C)** SIRT1 protein, **(D)** Catalase protein, **(E)** SIRT3 mRNA, **(F)** MnSOD mRNA (*n* = 9--10). mRNA levels of **(G)** SIRT3 and **(H)** MnSOD were obtained from quadriceps muscles from WT and PGC-1α KO mice 4 h after a single injection of saline or AICAR (500 mg/kg body weight, *n* = 6--8). Values are mean ± SEM. Interaction effects (treatment × genotype) were present for data in **(A, C)** (*p* \< 0.05), ^\*\*^ indicates vs. WT saline (*p* \< 0.01), †† indicates genotype effect vs. WT (*p* \< 0.01).](fphys-06-00085-g0006){#F6}

Combined effects of endurance exercise training and acute exercise on mitochondrial protein acetylation state in mouse quadriceps muscle
----------------------------------------------------------------------------------------------------------------------------------------

SIRT3 is involved in the activation of MnSOD by deacetylating K122. Deacetylation of this residue would be expected to occur if superoxides are produced in mitochondria during exercise. To determine whether SIRT3-mediated deacetylation of mitochondrial proteins in skeletal muscle is dependent on training status, and whether acute exercise in sedentary and exercise trained muscle would lead to a differentiated acetylation response, C57BL/6JBom mice were exercise trained or maintained as sedentary controls. On the day of tissue collection, mice were subjected to an acute 1-h bout of "moderate" or "high" intensity exercise or served as sedentary controls. Thus, using muscle samples from this experiment in addition to an antibody against acetylated K122 of MnSOD known to be important for MnSOD activity (Tao et al., [@B55]), the putative improved ability of trained muscle to handle ROS could be determined. To test the specificity of antibodies against total MnSOD and MnSOD K122 in skeletal muscle, we performed "split-blot" analyses and found bands from both antibodies to align in mouse and human skeletal muscle (Figure [7A](#F7){ref-type="fig"}). OSCP K139 antibody specificity has been previously validated (Vassilopoulos et al., [@B60]), and we further verified total OSCP and OSCP K139 specificity in skeletal muscle tissue by performing "split-blot" analyses and confirming that bands for OSCP and OSCP K139 align in human and mouse skeletal muscle (Figure [7B](#F7){ref-type="fig"}).

![**Validation of antibodies targeting acetylated residues of MnSOD and OSCP**. Validation of antibodies targeting **(A)** acetylated residue K122 of MnSOD and total MnSOD and **(B)** OSCP acetylation at residue K139 and total OSCP in mouse and human skeletal muscle by "split-blot" analysis.](fphys-06-00085-g0007){#F7}

First, we confirmed that exercise training increases SIRT3 protein content in mouse quadriceps muscle (Figure [8A](#F8){ref-type="fig"}). Unexpectedly, 60 min of high-intensity acute exercise caused further increases in SIRT3 protein abundance in both previously sedentary and trained mice (Figure [8A](#F8){ref-type="fig"}). This increase in protein content was not accompanied by a parallel increase in SIRT3 mRNA in these samples relative to samples from any of the other groups (data not shown). Contrary to the AMPK α2 KD/WT exercise training study described above (Figures [2E,F](#F2){ref-type="fig"}), SIRT1 and catalase protein levels increased in response to exercise training. No additional change occurred in response to acute exercise (Figures [8B,C](#F8){ref-type="fig"}). Furthermore, MnSOD protein levels increased with exercise training (Figure [8D](#F8){ref-type="fig"}) to a similar degree as WT mice in the AMPK α2 KD/WT training study (Figure [8D](#F8){ref-type="fig"} vs. Figure [2C](#F2){ref-type="fig"}).

![**Acute exercise does not result in deacetylation of MnSOD K122 or OSCP K139 in mouse skeletal muscle**. C57BL/6JBom mice were exercise trained for 5.5 weeks ("Trained") or kept as sedentary controls ("Sedentary"). On the day of tissue collection, both groups were further divided into three groups that either rested ("Control") or performed 60 min of treadmill running at either 12 m/min (0° incline; "Moderate") or 18 m/min (10° incline; "High" intensity). **(A)** SIRT3, **(B)** SIRT1 and **(C)** Catalase protein abundance was measured in quadriceps muscles after 1 h of treadmill exercise. **(D)** Total MnSOD, **(E)** MnSOD K122 acetylation levels and **(F)** MnSOD K122 acetylation levels normalized to total MnSOD levels. **(G)** Protein levels of the Complex V subunit, F~1~F~0~ ATP synthase oligomycin-sensitivity conferring protein (OSCP), **(H)** OSCP K139 acetylation levels and **(I)** OSCP K139 acetylation/total OSCP. Values are mean ± SEM. ^\*/\*\*^ indicates main effect vs. sedentary (*p* \< 0.05/0.01), ‡ main effect vs. control (*p* \< 0.01), *n* = 7--9.](fphys-06-00085-g0008){#F8}

Although the importance of mitochondria as a source of superoxides during muscle contraction has been questioned (McArdle et al., [@B35]), we assessed acetylation level of MnSOD in response to exercise training and an acute bout of exercise. We detected increased acetylation of MnSOD K122 in the samples from exercise-trained animals, whereas acetylation levels were unaffected by acute exercise (Figure [8E](#F8){ref-type="fig"}). When MnSOD K122 acetylation status was normalized to total MnSOD protein abundance, acetylation status remained unchanged across conditions (Figure [8F](#F8){ref-type="fig"}).

We also tested the hypothesis that acetylation of OSCP on the K139 residue is a marker of cellular energy stress, and that exercised trained muscle would be less susceptible to exercise-induced changes in K139 acetylation. OSCP protein abundance increased with exercise training in mouse quadriceps muscle (Figure [8G](#F8){ref-type="fig"}), in addition to a pronounced increase in acetylation of OSCP K139 (Figure [8H](#F8){ref-type="fig"}). When OSCP acetylation level was normalized to total OSCP protein, K139 acetylation increased with exercise training (Figure [8I](#F8){ref-type="fig"}). Contrary to our hypothesis, OSCP K139 acetylation relative to total OSCP was unaffected by acute exercise (Figures [8H,I](#F8){ref-type="fig"}).

Acetylation patterns in human *vastus lateralis* with acute exercise
--------------------------------------------------------------------

To compare the MnSOD and OSCP acetylation response obtained in exercised mouse quadriceps muscle with acutely exercised human skeletal muscle, we determined the acetylation level of these proteins in samples obtained from strenuously exercised *vastus lateralis* muscle of healthy young men. Acute exercise did not alter total protein abundance of either MnSOD or OSCP, nor did this intervention alter relative protein acetylation directly following exercise cessation (Figures [9A--F](#F9){ref-type="fig"}).

![**Acetylation status of MnSOD K122 and OSCP K139 is unaffected by acute exercise in human skeletal muscle**. Male subjects performed an acute bout (1 h) of one-legged extensor exercise at 80% peak work load after an over-night fast and *vastus lateralis* muscle biopsies from both legs were obtained before (Pre) and immediately after (Post) the exercise bout (*n* = 7). **(A)** MnSOD protein, **(B)** MnSOD K122 acetylation and **(C)** MnSOD K122 acetylation/MnSOD total protein abundance. **(D)** OSCP protein, **(E)** Acetylation status of OSCP K139 and **(F)** OSCP K139 normalized to total OSCP protein abundance. Values are mean ± SEM. No significant effects were observed.](fphys-06-00085-g0009){#F9}

Discussion {#s4}
==========

AMPK is a cellular "fuel gauge" that integrates and communicates disruptions in cellular energy charge to downstream targets (Hardie, [@B19]). One key signaling pathway by which AMPK exerts its effects is via the AMPK-PGC-1α-SIRT3 axis, which likely affects mitochondrial function and gene expression to adapt to metabolic changes (Hallows et al., [@B18]; Schwer et al., [@B49]; Someya et al., [@B52]; Tseng et al., [@B59]; Wu et al., [@B62]; Vassilopoulos et al., [@B60]). Here, we present evidence that AMPK is required for the increase in skeletal muscle SIRT3 and MnSOD protein abundance in addition to proteins in the mitochondrial respiratory complexes following exercise training and repeated AICAR treatment.

AMPK plays a critical role in mediating AICAR-induced increases in mitochondrial protein abundance (Jùrgensen et al., [@B24]). The present study confirms these findings and provides additional evidence that AMPK is required to fully beget exercise training-induced increases in mitochondrial oxidative phosphorylation complexes. This observation is in line with recent data showing that exercise training-induced adaptations in skeletal muscle on mitochondrial Complexes I-V are dependent on the upstream AMPK kinase, LKB1 (Tanner et al., [@B54]). Other studies employing the same (Abbott and Turcotte, [@B1]) or similar mouse models of AMPK deficiency (Röckl et al., [@B48]) as in the present investigation did not detect AMPK-dependent defects in the ability to increase mitochondrial protein content. However, these studies only assessed citrate synthase activity and did not report the abundance of electron transport chain proteins.

The one-legged endurance exercise training model represents a well-controlled method to study contraction-mediated adaptations in *vastus lateralis* muscle in humans (Andersen et al., [@B3]; Frøsig et al., [@B13]). Despite a relatively small sample size, we found near-significant increases in skeletal muscle MnSOD protein level in the trained, but not untrained leg of healthy volunteers. Conversely, SIRT3 protein levels were not increased. This is in conflict with emerging evidence that SIRT3 expression is increased in exercise-trained human and rodent skeletal muscle (Lanza et al., [@B28]; Palacios et al., [@B40]). While an early cross-sectional study reported higher protein activity of MnSOD in skeletal muscle of individuals with high aerobic fitness (Jenkins et al., [@B22]), some longitudinal studies have called these findings into question (Tiidus et al., [@B56]; Tonkonogi et al., [@B57]).

In our study, SIRT3 or ROS defense protein abundance was unaltered by exercise training in AMPK α2 KD mice. These results are inconsistent with the notion that SIRT3 may be induced by exercise in an AMPK-independent manner (Gurd et al., [@B16]). While 7 days of chronic electrical stimulation increased SIRT3 level in rat hind limb muscles, AICAR treatment had no effect (Gurd et al., [@B16]). Apart from obvious species and protocol differences between the two studies, these findings could also suggest additional, possibly time-sensitive, regulatory mechanisms of SIRT3 protein levels.

Activation of SIRT1 via deletion of poly (ADP-ribose) polymerase-1 (PARP-1), a major NAD-consuming enzyme, increases mitochondrial content (Bai et al., [@B4]). In the present study, SIRT1 and catalase protein abundance was not consistently increased with exercise training, despite a substantive increase in skeletal muscle SIRT3 protein levels in WT mice. These findings corroborate earlier reports showing that SIRT1 expression is not strongly correlated with contraction-induced changes in mitochondrial protein abundance (Chabi et al., [@B10]; Ringholm et al., [@B47]). A proportionally larger increase in SIRT1 activity, rather than protein abundance, may explain the enhanced response to endurance training and AICAR in WT mice in our study. For example, high-intensity interval training increases overall SIRT1 activity, despite decreasing SIRT1 protein concentration in humans (Gurd et al., [@B17]). However, SIRT1 is an NAD-dependent sirtuin, and we have previously reported that AMPK α2 KD, PGC-1α KO, and corresponding WT littermates respond similarly in increasing protein abundance of nicotinamide phosphoribosyltransferase, the rate-limiting enzyme in NAD recycling, in response to exercise training (Brandauer et al., [@B6]). These data suggest that the differential response in mitochondrial protein abundance following exercise training is unrelated to SIRT1 activation via NAD. Interestingly, PARP-1 deletion leads to an activation of SIRT1, but not SIRT3, suggesting possible differences in sirtuin activation in different cellular compartments (Bai et al., [@B4]).

While SIRT3 and MnSOD protein abundance increased in response to exercise training in WT mice, SIRT3, and MnSOD mRNA levels were unaffected in both genotypes. On the other hand, repeated AICAR treatment increased SIRT3 and MnSOD protein levels in an AMPK α2-dependent manner, while mRNA levels of SIRT3 and MnSOD were increased in both WT and AMPK α2 KD mice. These data strongly suggest that AMPK is involved in post-transcriptional regulation of SIRT3 and MnSOD gene products with AICAR. Although previous studies have failed to demonstrate a role for AMPK α2 in regulating gene expression in mouse skeletal muscle after acute exercise (Jùrgensen et al., [@B25]; Brandauer et al., [@B6]), we cannot rule out that AMPK could be important for promoting gene transcription of SIRT3 and MnSOD after exercise. Further studies are needed to clarify the differential effects of AICAR and exercise training on mRNA expression of these two genes.

We assessed the necessity of PGC-1α in mediating AICAR-induced increases in SIRT3 and MnSOD protein levels. While SIRT3 and MnSOD mRNA levels did not increase in WT or whole-body PGC-1α KO mice with either a single dose of AICAR or in response to repeated AICAR treatment, SIRT3 and MnSOD protein abundance with repeated AICAR treatment increased in WT mice but was abolished in PGC-1α KO mice. These mice also had drastically reduced SIRT3 and MnSOD protein abundance in untreated muscle, further underscoring the importance of PGC-1α in the maintenance of mitochondrial integrity. Although no data from exercise-trained PGC-1α KO muscle are presented here, exercise training restores muscle MnSOD concentration in a PGC-1α-independent manner in young mice (Geng et al., [@B14]), whereas the exercise training response on MnSOD protein levels has been found to be PGC-1α-dependent in old mice (Leick et al., [@B32]; Olesen et al., [@B39]).

Our data on mitochondrial protein abundance should be interpreted in context with previously published literature on fiber type switching following exercise training or AICAR administration. AMPK and PGC-1α are vital regulators of cellular metabolic adaptations, and a functional AMPK α2 subunit appears to be required to fully realize training-induced IIb to IIa/x fiber type conversion (Röckl et al., [@B48]). Repeated AICAR treatment alone may be insufficient to change skeletal muscle fiber type (Bamford et al., [@B5]; Putman et al., [@B43]), although data from dystrophic mice indicates that AICAR may cause a phenotypic shift toward a more slow-twitch, oxidative fiber type under some circumstances (Ljubicic et al., [@B33]). PGC-1α is not only a major stimulator of mitochondrial biogenesis but also promotes type II to type I fiber type conversion (Lee et al., [@B29]), along with other factors such as calcineurin (Naya et al., [@B37]). Our data and these lines of evidence further support the notion that AMPK and PGC-1α are centrally important regulators of metabolic and contractile performance of mammalian skeletal muscle. However, the finding that AICAR treatment increases mitochondrial biogenesis, but may not necessarily change fiber type suggests that these processes may commonly occur in tandem but not be regulated by the same physiological stimuli.

SIRT3 is known to have deacetylase activity in the mitochondrion (Lombard et al., [@B34]). MnSOD activity is regulated through deacetylation via SIRT3 and plays an important role in handling and regulating ROS levels in mitochondria (Ahn et al., [@B2]; Tao et al., [@B55]). MnSOD has multiple acetylation sites (Rardin et al., [@B45]) where key lysine residues (e.g., K68 and K122) are deacetylated in response to exercise and cellular stress (Tao et al., [@B55]). To elucidate the interplay between aerobic fitness and stress induced by acute exercise, trained or untrained WT mice were subjected to an acute bout of "moderate" or "high"-intensity exercise, or assigned to a non-exercise control group. Despite the substantial increase in SIRT3 protein abundance, acetylation of regulatory lysine residue K122 of MnSOD or K139 of OSCP was not reduced in exercise-trained and/or acutely exercised mice at the various exercise intensities. Rather, when normalized to total protein levels, MnSOD K122 acetylation was unaltered between exercise trained and untrained mice, whereas acetylation status of K139 on OSCP was increased. This exercise training-induced increase in MnSOD implicates an enhanced cellular ROS handling capacity. However, our data on MnSOD and OSCP acetylation following acute exercise are not in obvious agreement with reported exercise-induced reductions in acetylation of these sites (Vassilopoulos et al., [@B60]). One difference between the two exercise protocols is that all mice in the present study completed the "moderate" and "high" intensity exercise bouts, while the exercise protocol in the previous study (Vassilopoulos et al., [@B60]) was exhaustive. Exhaustive exercise may be required to detect an appreciable deacetylation of MnSOD and OSCP at these lysine residues. The lack of exercise-induced changes in MnSOD and OSCP acetylation was compared with human skeletal muscle samples obtained in conjunction with a one-legged exercise protocol. Under these conditions, we also failed to observe a differential regulation of MnSOD K122 and OSCP K139 between the exercised and sedentary legs. Thus, the effects of acute exercise on MnSOD and OSCP deacetylation may vary across different experimental models and organisms. Further studies are warranted to determine the exact factors regulating SIRT3-regulated protein deacetylation with acute exercise.

The substantial increase in K139 acetylation we found after exercise training in mice may seem counterintuitive. One explanation for this observed increased OSCP acetylation could be that total cellular mitochondrial content is enhanced. Exercise training may thus have resulted in an ATP-generating potential that surpasses the actual need for ATP, leading to ATP synthase inhibition via OSCP acetylation. Another possibility is that lysine residues other than K139 on OSCP or lysines on other subunits of the ATP synthase are important for ATP synthase activity, and that acetylation status of these is changed in response to training.

The fact that concentrations of the mitochondrial SIRT3 protein were more than 3-fold higher in exercise-trained compared with untrained mice presents an intriguing observation. Why increased deacetylase protein concentration would result in unchanged or even increased acetylation levels in MnSOD or OSCP, respectively, is not immediately clear. In this context, a previous study reported that SIRT3 reduces mitochondrial protein synthesis via deacetylation of the ribosomal protein MRPL10 (Yang et al., [@B63]). Such an adaptation would induce an ATP-"sparing" effect that would preserve ATP pools for cross-bridge cycling and maintaining calcium homeostasis. In short, an acute increase in SIRT3 protein or activity is consistent with an inhibition of protein synthesis and other energetically costly processes by AMPK activation (Jensen et al., [@B23]; Hardie, [@B19]; White and Schenk, [@B61]).

In conclusion, we provide evidence for both AMPK and PGC-1α in regulating protein abundance of SIRT3 and MnSOD. These proteins are important for the regulation of mitochondrial adaptation and the handling of ROS, respectively. The interactive effects of acute and chronic exercise on MnSOD and OSCP acetylation status constitute an unexplored avenue, with implications for intensity- and duration-dependent mitochondrial adaptations that warrant further investigation.
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